科研成果详情

题名IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms
作者
会议录名称BLOOD   影响因子和分区
语种英语
原始文献类型Meeting Abstract
会议名称65th Annual Meeting of the American-Society-of-Hematology (ASH)
会议日期DEC 09-12, 2023
会议地点San Diego, CA
出版地WASHINGTON
ISSN0006-4971
EISSN1528-0020
DOI10.1182/blood-2023-189068
页数3
WOS类目Hematology
WOS研究方向Hematology
WOS记录号WOS:001159740304190
收录类别SCIE ; CPCI ; CPCI-S
发表日期2023-11-02
引用统计
文献类型会议论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/210063
专题附属第一医院_血液内科
其他_附属台州医院(浙江省台州医院)
作者单位
1.Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China;
2.Ningbo First Hosp, Dept Hematol, Ningbo, Peoples R China;
3.Zhejiang Prov Peoples Hosp, Dept Hematol, Hangzhou, Peoples R China;
4.Yinzhou Peoples Hosp, Dept Hematol, Ningbo, Peoples R China;
5.Zhejiang Chinese Med Univ, Dept Hematol, Affiliated Hosp 1, Zhejiang Prov Hosp Chinese Med, Hangzhou, Peoples R China;
6.Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou, Peoples R China;
7.Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China;
8.Wenzhou Med Coll, Taizhou Hosp Zhejiang Prov, Dept Hematol, Taizhou, Peoples R China;
9.Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Hematol, Sch Med, Hangzhou, Peoples R China;
10.Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Hematol, Hangzhou, Peoples R China;
11.Jinhua Cent Hosp, Dept Hematol, Jinhua, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Yang, Tingting,Jiang, Bingqian,Luo, Yi,et al. IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms[C]. WASHINGTON,2023.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Yang, Tingting]的文章
[Jiang, Bingqian]的文章
[Luo, Yi]的文章
百度学术
百度学术中相似的文章
[Yang, Tingting]的文章
[Jiang, Bingqian]的文章
[Luo, Yi]的文章
必应学术
必应学术中相似的文章
[Yang, Tingting]的文章
[Jiang, Bingqian]的文章
[Luo, Yi]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。